Pharmacologic Characterization of Omidenepag Isopropyl, a Novel Selective EP2 Receptor Agonist, as an Ocular Hypotensive Agent
2018 ◽
Vol 59
(1)
◽
pp. 145
◽
2000 ◽
Vol 267
(13)
◽
pp. 4281-4289
◽
2003 ◽
Vol 11
(13)
◽
pp. 2709-2714
◽
2010 ◽
Vol 334
(3)
◽
pp. 863-874
◽
2001 ◽
Vol 281
(1)
◽
pp. F114-F122
◽